News & events

Latest news and upcoming events

Every day we make new research discoveries, deliver excellence in education and forge partnerships that have a global impact.

Search news

Browse by category

Browse:

Select all - Clear all

Monash contributions to diversity and inclusion recognised

Monash University has reaffirmed its commitment to fairness and protection to all regardless of gender, race, religion, ethnicity, or sexual orientation, with the Vice-Chancellor’s Diversity and Inclusion Awards, presented on Wednesday 30

University news

Monash scientists gain multimillion-dollar NIH grant for ‘superbug’ drug discovery program

A world-leading team, led by Professor Jian Li from BDI, has been awarded a multi-million dollar grant by the US National Institutes of Health (NIH) to further its pioneering work on drug discovery, tackling antibiotic-resistant 'superbugs'.

Medicine & health

New partnership between Monash Biomedicine Discovery Institute and MRCF to keep taxpayer-funded research in Australia

The newly-established Monash Biomedicine Discovery Institute (BDI) has become a member of the Medical Research Commercialisation Fund (MRCF).

Medicine & health

Superbug battle bolstered by major US National Institutes of Health grant

Monash Biomedicine Discovery Institute (BDI) scientists investigating antibiotic-resistant 'superbugs' have secured a highly competitive US National Institutes of Health (NIH) grant to boost their internationally leading research.

Medicine & health
web

Monash scientist honoured by prestigious UK Medical Fellowship

Monash University scientist, Professor Jamie Rossjohn, has been elected to the Fellowship of the Academy of Medical Sciences in the UK.

Medicine & health
image

Monash announces collaboration with Johnson & Johnson innovation for rheumatoid arthritis detection and treatment

Monash University has signed a major multiyear research and commercialisation deal with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical companies of Johnson & Johnson, for the early detection and prevention of rheumatoid

Industry & partnerships

Monash University and Corvus Pharmaceuticals enter into exclusive license agreement for Novel Immuno-Oncology Program

Monash University and Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, have announced today they have entered into an exclusive agreement. Under the agreement, Corvus has licensed global rights to an

Medicine & health